3D Printed Drugs
SKU
MRR-431C35F6C179
Region
Global
Publication Date
March 2024
Delivery
Immediate
2023
USD 292.72 million
2030
USD 744.29 million
2024
USD 331.22 million
CAGR
14.26%
3D Printed Drugs Market by Technology (Direct-Write, Fused Deposition Modelling, Inkjet Printing), Dose Form (Capsule, Nanoparticles, Tablet), Application, End-User - Global Forecast 2024-2030

[191 Pages Report] The 3D Printed Drugs Market size was estimated at USD 292.72 million in 2023 and expected to reach USD 331.22 million in 2024, at a CAGR 14.26% to reach USD 744.29 million by 2030.

3D Printed Drugs Market
To learn more about this report, request a free PDF copy

3D printed drugs refer to the emerging use of 3D printing technology to create pharmaceutical products with improved drug delivery mechanisms. 3D printing of drugs enables personalization, precision, and cost-efficiency in drug manufacturing. The proliferation of 3D printed drugs is transforming the pharmaceutical industry, enabling the design of medications in any desired shape, size, dose, and delivery rate, delivering personalized healthcare for patients. Increased drug discovery and development activities and an inclination towards a personalized medicines approach are raising the need for advanced drug manufacturing techniques such as 3D printing of drugs. However, the high upfront cost of 3D printing technology may adversely impact the production of 3D printed drugs. Moreover, technological advancements in 3D printing technology are expected to enhance drug production efficiency, which is anticipated to expand its use for the development of drugs.

3D Printed Drugs Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Technology: Direct-write technology provides personalized and effective medication solutions

Direct-write technology in the context of 3D printed drugs involves using precise deposition methods to create pharmaceutical products with controlled structures and compositions. This approach allows for the customization of drug formulations, enabling personalized medicine and more effective drug delivery. Fused deposition modeling (FDM), a widely used 3D printing technology, has also found application in the pharmaceutical industry to develop 3D-printed drugs. Inkjet printing technology has found applications in the pharmaceutical industry for 3D printing drugs, offering a precise and controlled method for depositing pharmaceutical materials. Powder bed printing technology holds promise in the pharmaceutical industry for creating customized and controlled drug delivery systems. Using stereolithography technology in 3D printing drugs shows promise for creating custom, controlled-release pharmaceuticals with precise dosages.

Dose Form: Potential adoption of 3D printed drugs in the form of capsule

3D printing allows for creating personalized and patient-specific doses, potentially optimizing treatment plans. Capsules can be 3D printed with multiple compartments, each containing a different drug or dosage, facilitating combination therapies. 3D printing at the nanoscale allows for the fabrication of drug-loaded nanoparticles with controlled release properties, optimizing drug delivery. 3D printing can encapsulate active pharmaceutical ingredients within nanoparticles, protecting them from degradation and ensuring stability. Tablets produced through 3D printing can be customized to individual patient needs, allowing for personalized dosages and treatment plans. 3D printing enables the creation of tablets with complex geometries, such as porous structures or multilayered designs, influencing drug release kinetics.

Application: Proliferating use for manufacturing of neurology drugs

3D printed drugs revolutionize dental care by offering personalized solutions such as customized aligners, dentures, and crowns. Customized drug delivery systems enable precise medication release for conditions such as periodontal diseases. This technology enhances treatment efficacy while minimizing side effects. In dental implants, 3D printing facilitates the creation of drug-loaded scaffolds, promoting faster healing and reducing the risk of infections. In neurology, 3D printed drugs are crucial in tailoring treatments for neurological disorders. Patient-specific drug formulations enable precise dosing, enhancing therapeutic outcomes for conditions such as epilepsy and neurodegenerative diseases. 3D printing transforms orthopedic medicine by enabling the fabrication of patient-specific medications and implants. In orthopedic drug delivery, 3D printing allows for development of personalized dosage forms tailored to the patient's needs. Moreover, 3D printed implants with incorporated drugs enhance the healing process, providing controlled and localized drug release to address inflammation and promote bone regeneration.

End-User: Significant penetration of 3D printed drugs in clinics & hospitals

In clinics & hospitals, medical professionals are focusing on delivering personalized medications and prefer 3D printed drugs tailored to meet specific patient needs. These 3D printed drugs are preferred as they increase the effectiveness of treatments and reduce the risks and side effects commonly associated with traditional, mass-produced medications. Research laboratories heavily utilize 3D printed drugs due to their precision and accuracy. 3D printed drugs enable researchers to conduct concrete studies and rigorous research on drug interactions and medicinal effectiveness. Specialty clinics, such as those built around personalized medical treatments, increasingly leverage 3D printed drugs to cater to their unique patient needs. Personalized medication could enhance patient compliance and treatment efficiency since medication could be tailored to each patient’s unique physiology. Clinics & hospitals, and special clinics widely adopt 3D printed drugs for enhanced patient treatment protocols, while research laboratories focus on the tangible benefits they provide for medical innovation and drug testing.

Regional Insights

The Americas have a significant landscape in the 3D-printed drugs market owing to progressive medical research and development, the robust pharmaceutical industry, and the presence of key 3D-printed drug manufacturers. Rising technological advancements and enhanced healthcare infrastructure further advance the market landscape in the region. Europe has observed a significant market for 3D printed drugs, driven by a rising geriatric population, initiatives towards personalized medicine, supportive governmental regulations, and funding activities from government and key manufacturers. In the Middle East & Africa, increasing investments in technological adoption and healthcare infrastructure enhancement contribute to market growth. The Asia-Pacific region is witnessing an emerging stage in the 3D printed drugs market and shows significant growth potential driven by factors such as rapid urbanization, innovations in healthcare technologies, increasing healthcare expenditures, and a rising elderly population requiring customized medication.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the 3D Printed Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the 3D Printed Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • CurifyLabs Launches 3D Printing Solution For Personalised Medicine

    CurifyLabs introduced GMP (good manufacturing practice) produced Pharma Inks for 3D printable medicines, facilitating a novel solution for producing patient-tailored and personalized medicines in pharmacies and hospitals. CurifyLabs’ Pharma Kit, including automated 3D printing technology and printable pharmaceutical inks, allows wider adoption of personalized medicine, resulting in better future care for patients. [Published On: 2023-10-17]

  • Cellink And Carcinotech Partner To Transform Cancer Drug Development With 3d Bioprinting

    Carcinotech and 3D bioprinting firm CELLINK collaborated to accelerate cancer drug development with 3D bioprinted tumor models. The partnership focuses on the development and commercialization of cutting-edge protocols for the fabrication of 3D bioprinted tumor models using cancer cell lines. These models are designed to significantly improve accuracy and speed up drug development processes, ultimately reducing development costs and enhancing research output. [Published On: 2023-10-09]

  • Triastek Receives FDA IND Clearance for 3D Printed Medicine for the Treatment of Ulcerative Colitis

    Triastek, Inc. received U.S. FDA clearance for its investigational new drug (IND) application for clinical studies of the T21, 3D printed medicine related to potential treatment for ulcerative colitis. T21 is a potential treatment capable of colon-targeted drug delivery. With a unique 3D dosage form design, T21 can reach the targeted colon segment of the GI tract, thus permitting the use of a lower drug dose than the reference-listed drug, which provides systemic exposure. [Published On: 2022-11-21]

Key Company Profiles

The report delves into recent significant developments in the 3D Printed Drugs Market, highlighting leading vendors and their innovative profiles. These include 3D Systems, Inc., 3DR HOLDINGS, Anatomics Pty Ltd, Aprecia Pharmaceuticals, LLC, AstraZeneca plc, BioDuro, LLC, Biomedical Modeling Inc., Cycle Pharmaceuticals, Cyfuse Biomedical K.K., EnvisionTEC GmbH, FabRx Ltd., General Electric Company, GlaxoSmithKline Plc, Materialise NV, Merck KGaA, Organovo Holdings Inc., Proto Labs Inc., Renishaw PLC, Rokit Healthcare Inc., Siemens AG, Stratasys Ltd., Triastek, Inc., TVASTA, Yissum, and Zortrax S.A..

Market Segmentation & Coverage

This research report categorizes the 3D Printed Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Direct-Write
    • Fused Deposition Modelling
    • Inkjet Printing
    • Powder Bed Printing
    • Stereolithography
    • Zip Dose
  • Dose Form
    • Capsule
    • Nanoparticles
    • Tablet
  • Application
    • Dental
    • Neurology
    • Orthopedic
  • End-User
    • Clinics & Hospitals
    • Research Laboratories
    • Speciality Clinics

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the 3D Printed Drugs Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the 3D Printed Drugs Market?
  3. What are the technology trends and regulatory frameworks in the 3D Printed Drugs Market?
  4. What is the market share of the leading vendors in the 3D Printed Drugs Market?
  5. Which modes and strategic moves are suitable for entering the 3D Printed Drugs Market?

Table of Contents
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Define: Research Objective
    2. Determine: Research Design
    3. Prepare: Research Instrument
    4. Collect: Data Source
    5. Analyze: Data Interpretation
    6. Formulate: Data Verification
    7. Publish: Research Report
    8. Repeat: Report Update
  3. Executive Summary
  4. Market Overview
  5. Market Insights
    1. Market Dynamics
      1. Drivers
        1. Surge in demand for instantaneous soluble drugs
        2. Growing adoption of personalized drugs and the production of combination medicine
        3. Extensive use of 3D printed technology for manufacturing cancer drugs
      2. Restraints
        1. Material limitations associated with manufacturing of 3D printed drugs
      3. Opportunities
        1. Constant technological developments in 3D printing technique
        2. Significant investments for manufacturing of 3D printed pharmaceuticals
      4. Challenges
        1. Complexities in manufacturing of 3D printed drugs
    2. Market Segmentation Analysis
      1. Technology: Direct-write technology provides personalized and effective medication solutions
      2. Dose Form: Potential adoption of 3D printed drugs in the form of capsule
      3. Application: Proliferating use for manufacturing of neurology drugs
      4. End-User: Significant penetration of 3D printed drugs in clinics & hospitals
    3. Market Trend Analysis
    4. Cumulative Impact of High Inflation
    5. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    6. Value Chain & Critical Path Analysis
    7. Regulatory Framework
  6. 3D Printed Drugs Market, by Technology
    1. Introduction
    2. Direct-Write
    3. Fused Deposition Modelling
    4. Inkjet Printing
    5. Powder Bed Printing
    6. Stereolithography
    7. Zip Dose
  7. 3D Printed Drugs Market, by Dose Form
    1. Introduction
    2. Capsule
    3. Nanoparticles
    4. Tablet
  8. 3D Printed Drugs Market, by Application
    1. Introduction
    2. Dental
    3. Neurology
    4. Orthopedic
  9. 3D Printed Drugs Market, by End-User
    1. Introduction
    2. Clinics & Hospitals
    3. Research Laboratories
    4. Speciality Clinics
  10. Americas 3D Printed Drugs Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  11. Asia-Pacific 3D Printed Drugs Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. Singapore
    10. South Korea
    11. Taiwan
    12. Thailand
    13. Vietnam
  12. Europe, Middle East & Africa 3D Printed Drugs Market
    1. Introduction
    2. Denmark
    3. Egypt
    4. Finland
    5. France
    6. Germany
    7. Israel
    8. Italy
    9. Netherlands
    10. Nigeria
    11. Norway
    12. Poland
    13. Qatar
    14. Russia
    15. Saudi Arabia
    16. South Africa
    17. Spain
    18. Sweden
    19. Switzerland
    20. Turkey
    21. United Arab Emirates
    22. United Kingdom
  13. Competitive Landscape
    1. Market Share Analysis, 2023
    2. FPNV Positioning Matrix, 2023
    3. Competitive Scenario Analysis
      1. CurifyLabs Launches 3D Printing Solution For Personalised Medicine
      2. Cellink And Carcinotech Partner To Transform Cancer Drug Development With 3d Bioprinting
      3. Triastek Receives FDA IND Clearance for 3D Printed Medicine for the Treatment of Ulcerative Colitis
  14. Competitive Portfolio
    1. Key Company Profiles
    2. Key Product Portfolio
  15. List of Figures [Total: 24]
    1. 3D PRINTED DRUGS MARKET RESEARCH PROCESS
    2. 3D PRINTED DRUGS MARKET SIZE, 2023 VS 2030
    3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
    4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    6. 3D PRINTED DRUGS MARKET DYNAMICS
    7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
    8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
    9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2023 VS 2030 (%)
    10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
    11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
    12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
    13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
    14. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
    15. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    16. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    17. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    18. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    19. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    20. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    21. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    22. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    23. 3D PRINTED DRUGS MARKET SHARE, BY KEY PLAYER, 2023
    24. 3D PRINTED DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  16. List of Tables [Total: 382]
    1. 3D PRINTED DRUGS MARKET SEGMENTATION & COVERAGE
    2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2023 (USD MILLION)
    4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2024-2030 (USD MILLION)
    5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
    6. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
    7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY REGION, 2018-2023 (USD MILLION)
    10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY REGION, 2024-2030 (USD MILLION)
    11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY REGION, 2018-2023 (USD MILLION)
    12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY REGION, 2024-2030 (USD MILLION)
    13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY REGION, 2018-2023 (USD MILLION)
    14. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY REGION, 2024-2030 (USD MILLION)
    15. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY REGION, 2018-2023 (USD MILLION)
    16. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY REGION, 2024-2030 (USD MILLION)
    17. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
    18. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
    19. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY REGION, 2018-2023 (USD MILLION)
    20. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY REGION, 2024-2030 (USD MILLION)
    21. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    22. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    23. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2023 (USD MILLION)
    24. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2024-2030 (USD MILLION)
    25. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2023 (USD MILLION)
    26. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NANOPARTICLES, BY REGION, 2024-2030 (USD MILLION)
    27. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2023 (USD MILLION)
    28. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TABLET, BY REGION, 2024-2030 (USD MILLION)
    29. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    30. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    31. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DENTAL, BY REGION, 2018-2023 (USD MILLION)
    32. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DENTAL, BY REGION, 2024-2030 (USD MILLION)
    33. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
    34. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
    35. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2023 (USD MILLION)
    36. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2024-2030 (USD MILLION)
    37. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    38. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    39. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
    40. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
    41. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
    42. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
    43. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2018-2023 (USD MILLION)
    44. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2024-2030 (USD MILLION)
    45. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    46. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    47. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    48. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    49. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    50. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    51. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    52. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    53. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    54. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    55. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    56. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    57. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    58. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    59. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    60. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    61. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    62. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    63. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    64. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    65. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    66. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    67. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    68. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    69. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    70. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    71. CANADA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    72. CANADA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    73. CANADA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    74. CANADA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    75. CANADA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    76. CANADA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    77. CANADA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    78. CANADA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    79. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    80. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    81. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    82. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    83. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    84. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    85. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    86. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    87. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    88. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    89. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    90. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    91. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    92. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    93. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    94. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    95. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
    96. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
    97. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    98. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    99. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    100. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    101. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    102. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    103. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    104. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    105. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    106. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    107. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    108. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    109. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    110. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    111. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    112. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    113. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    114. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    115. CHINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    116. CHINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    117. CHINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    118. CHINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    119. CHINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    120. CHINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    121. CHINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    122. CHINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    123. INDIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    124. INDIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    125. INDIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    126. INDIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    127. INDIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    128. INDIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    129. INDIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    130. INDIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    131. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    132. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    133. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    134. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    135. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    136. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    137. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    138. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    139. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    140. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    141. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    142. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    143. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    144. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    145. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    146. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    147. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    148. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    149. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    150. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    151. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    152. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    153. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    154. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    155. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    156. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    157. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    158. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    159. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    160. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    161. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    162. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    163. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    164. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    165. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    166. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    167. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    168. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    169. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    170. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    171. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    172. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    173. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    174. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    175. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    176. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    177. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    178. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    179. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    180. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    181. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    182. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    183. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    184. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    185. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    186. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    187. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    188. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    189. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    190. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    191. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    192. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    193. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    194. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    195. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    196. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    197. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    198. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    199. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    200. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    201. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    202. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    203. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    204. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    205. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    206. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    207. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    208. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    209. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    210. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    211. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    212. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    213. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    214. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    215. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    216. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    217. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    218. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    219. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    220. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    221. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    222. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    223. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    224. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    225. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    226. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    227. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    228. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    229. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    230. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    231. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    232. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    233. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    234. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    235. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    236. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    237. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    238. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    239. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    240. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    241. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    242. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    243. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    244. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    245. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    246. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    247. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    248. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    249. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    250. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    251. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    252. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    253. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    254. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    255. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    256. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    257. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    258. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    259. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    260. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    261. ITALY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    262. ITALY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    263. ITALY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    264. ITALY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    265. ITALY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    266. ITALY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    267. ITALY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    268. ITALY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    269. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    270. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    271. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    272. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    273. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    274. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    275. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    276. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    277. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    278. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    279. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    280. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    281. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    282. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    283. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    284. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    285. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    286. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    287. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    288. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    289. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    290. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    291. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    292. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    293. POLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    294. POLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    295. POLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    296. POLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    297. POLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    298. POLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    299. POLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    300. POLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    301. QATAR 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    302. QATAR 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    303. QATAR 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    304. QATAR 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    305. QATAR 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    306. QATAR 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    307. QATAR 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    308. QATAR 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    309. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    310. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    311. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    312. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    313. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    314. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    315. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    316. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    317. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    318. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    319. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    320. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    321. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    322. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    323. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    324. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    325. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    326. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    327. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    328. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    329. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    330. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    331. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    332. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    333. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    334. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    335. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    336. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    337. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    338. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    339. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    340. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    341. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    342. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    343. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    344. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    345. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    346. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    347. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    348. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    349. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    350. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    351. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    352. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    353. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    354. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    355. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    356. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    357. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    358. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    359. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    360. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    361. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    362. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    363. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    364. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    365. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    366. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    367. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    368. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    369. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    370. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    371. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    372. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    373. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    374. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    375. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
    376. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
    377. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    378. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    379. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    380. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    381. 3D PRINTED DRUGS MARKET SHARE, BY KEY PLAYER, 2023
    382. 3D PRINTED DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  17. List of Companies Mentioned [Total: 25]
    1. 3D Systems, Inc.
    2. 3DR HOLDINGS
    3. Anatomics Pty Ltd
    4. Aprecia Pharmaceuticals, LLC
    5. AstraZeneca plc
    6. BioDuro, LLC
    7. Biomedical Modeling Inc.
    8. Cycle Pharmaceuticals
    9. Cyfuse Biomedical K.K.
    10. EnvisionTEC GmbH
    11. FabRx Ltd.
    12. General Electric Company
    13. GlaxoSmithKline Plc
    14. Materialise NV
    15. Merck KGaA
    16. Organovo Holdings Inc.
    17. Proto Labs Inc.
    18. Renishaw PLC
    19. Rokit Healthcare Inc.
    20. Siemens AG
    21. Stratasys Ltd.
    22. Triastek, Inc.
    23. TVASTA
    24. Yissum
    25. Zortrax S.A.
Frequently Asked Questions about the 3D Printed Drugs Market
The Global 3D Printed Drugs Market size was estimated at USD 292.72 million in 2023 and expected to reach USD 331.22 million in 2024.
The Global 3D Printed Drugs Market to grow USD 744.29 million by 2030, at a CAGR of 14.26%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.